These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1428466)

  • 1. Topical corticosteroids: quality control considerations.
    Shah VP
    Int J Dermatol; 1992 Oct; 31 Suppl 1():34-7. PubMed ID: 1428466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro release of hydrocortisone from topical preparations and automated procedure.
    Shah VP; Elkins J; Hanus J; Noorizadeh C; Skelly JP
    Pharm Res; 1991 Jan; 8(1):55-9. PubMed ID: 2014209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New approaches to assess topical corticosteroid bioequivalence: pharmacokinetic evaluation.
    Pershing LK
    Int J Dermatol; 1992 Oct; 31 Suppl 1():14-20. PubMed ID: 1428461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the test system used for in vitro release of drugs for topical dermatological drug products.
    Shah VP; Elkins JS; Williams RL
    Pharm Dev Technol; 1999 Aug; 4(3):377-85. PubMed ID: 10434283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Release of hydrocortisone from a cream matrix: dependency of release on suspension concentration and measurement of solubility and diffusivity.
    Pillai R; Shah V; Abriola L; Caetano P; Flynn GL
    Pharm Dev Technol; 2001 Aug; 6(3):373-84. PubMed ID: 11485179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing the effect of vehicles on topical delivery: understanding the basic relationship between solvent and solute penetration using silicone membranes.
    Cross SE; Pugh WJ; Hadgraft J; Roberts MS
    Pharm Res; 2001 Jul; 18(7):999-1005. PubMed ID: 11496961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and evaluation of a proniosome hydrocortisone gel in comparison with a commercial cream.
    Sankar V; Praveen C; Prasanth KG; Srinivas CR; Ruckmann K
    Pharmazie; 2009 Nov; 64(11):731-4. PubMed ID: 20099517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro release of betamethasone dipropionate from petrolatum-based ointments.
    Zatz JL; Varsano J; Shah VP
    Pharm Dev Technol; 1996 Oct; 1(3):293-8. PubMed ID: 9552312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topically used corticosteroids: What is the big picture of drug product degradation?
    van Heugten AJP; de Boer W; de Vries WS; Pieters RJ; Vromans H
    Eur J Pharm Sci; 2018 May; 117():1-7. PubMed ID: 29407556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between in vivo skin blanching and in vitro release rate for betamethasone valerate creams.
    Shah VP; Elkins J; Skelly JP
    J Pharm Sci; 1992 Jan; 81(1):104-6. PubMed ID: 1619561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing equivalence of innovator and generic formulations of betamethasone dipropionate cream and ointment.
    Sequira J; Berardi M; Chan TM; Letarte J; Malchow R; Pramanick B; Wolkoff HN
    Clin Ther; 1991; 13(6):687-94. PubMed ID: 1790543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of drug availability from commercial topical formulations with a multilayer membrane model].
    Neubert R; Winter K; Bendas B
    Pharmazie; 1993 Jan; 48(1):54-6. PubMed ID: 8460175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative efficacy of glucocorticoid preparations in the local therapy of inflammatory degenerative diseases of the locomotor apparatus].
    Bel'kov AV; Vavulov IuA
    Voen Med Zh; 2001 Sep; 322(9):58-61. PubMed ID: 11668794
    [No Abstract]   [Full Text] [Related]  

  • 14. The relevance of polymeric synthetic membranes in topical formulation assessment and drug diffusion study.
    Ng SF; Rouse JJ; Sanderson FD; Eccleston GM
    Arch Pharm Res; 2012 Mar; 35(4):579-93. PubMed ID: 22553050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and evaluation of buccal adhesive hydrocortisone acetate (HCA) tablets.
    Ceschel GC; Maffei P; Lombardi Borgia S; Ronchi C
    Drug Deliv; 2001; 8(3):161-71. PubMed ID: 11570597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stabilization of dithranol in topical formulations.
    Thoma K; Holzmann C
    Acta Pharm Hung; 1998 Nov; 68(6):313-21. PubMed ID: 9987194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical corticosteroids: a review of properties and principles in therapeutic use.
    Chaffman MO
    Nurse Pract Forum; 1999 Jun; 10(2):95-105. PubMed ID: 10542586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UVB photolysis of betamethasone and its esters: characterization of photoproducts in solution, in pig skin and in drug formulations.
    Miolo G; Gallocchio F; Levorato L; Dalzoppo D; Beyersbergen van Henegouwen GM; Caffieri S
    J Photochem Photobiol B; 2009 Jul; 96(1):75-81. PubMed ID: 19450988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of methylparaben, propylparaben, triamcinolone acetonide and its degradation product in a topical cream by RP-HPLC.
    Matysová L; Hájková R; Sícha J; Solich P
    Anal Bioanal Chem; 2003 Jun; 376(4):440-3. PubMed ID: 12819846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro release of nitroglycerin from topical products by use of artificial membranes.
    Wu ST; Shiu GK; Simmons JE; Bronaugh RL; Skelly JP
    J Pharm Sci; 1992 Dec; 81(12):1153-6. PubMed ID: 1491329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.